Related references
Note: Only part of the references are listed.MicroRNAs Regulate Tumor Angiogenesis Modulated by Endothelial Progenitor Cells
Prue N. Plummer et al.
CANCER RESEARCH (2013)
Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFα
Caroline Swan et al.
GUT (2013)
Down-modulation of TNFSF15 in ovarian cancer by VEGF and MCP-1 is a pre-requisite for tumor neovascularization
Weimin Deng et al.
ANGIOGENESIS (2012)
VEGFR1 stimulates a CXCR4-dependent translocation of megakaryocytes to the vascular niche, enhancing platelet production in mice
Simon C. Pitchford et al.
BLOOD (2012)
Soluble FLT1 Binds Lipid Microdomains in Podocytes to Control Cell Morphology and Glomerular Barrier Function
Jing Jin et al.
CELL (2012)
Critical Reevaluation of Endothelial Progenitor Cell Phenotypes for Therapeutic and Diagnostic Use
Gian Paolo Fadini et al.
CIRCULATION RESEARCH (2012)
VEGFR-1 Mediates Endothelial Differentiation and Formation of Blood Vessels in a Murine Model of Infantile Hemangioma
Elisa Boscolo et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Vascular endothelial growth inhibitor (VEGI; TNFSF15) inhibits bone marrow-derived endothelial progenitor cell incorporation into Lewis lung carcinoma tumors
Paulina H. Liang et al.
ANGIOGENESIS (2011)
Up-regulation of soluble vascular endothelial growth factor receptor-1 prevents angiogenesis in hypertrophied myocardium
Elisabeth Kaza et al.
CARDIOVASCULAR RESEARCH (2011)
MicroRNA-126 modulates endothelial SDF-1 expression and mobilization of Sca-1+/Lin- progenitor cells in ischaemia
Coen van Solingen et al.
CARDIOVASCULAR RESEARCH (2011)
Flt1 acts as a negative regulator of tip cell formation and branching morphogenesis in the zebrafish embryo
Janna Krueger et al.
DEVELOPMENT (2011)
Impact of soluble fms-like tyrosine kinase-1 and placental growth factor serum levels for risk stratification and early diagnosis in patients with suspected acute myocardial infarction
Willibald Hochholzer et al.
EUROPEAN HEART JOURNAL (2011)
Delivery of Soluble VEGF Receptor 1 (sFlt1) by Gene Electrotransfer as a New Antiangiogenic Cancer Therapy
Julien Verrax et al.
MOLECULAR PHARMACEUTICS (2011)
LITAF and TNFSF15, two downstream targets of AMPK, exert inhibitory effects on tumor growth
J. Zhou et al.
ONCOGENE (2011)
Jumonji domain-containing protein 6 (Jmjd6) is required for angiogenic sprouting and regulates splicing of VEGF-receptor 1
Jes-Niels Boeckel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Using the Transcription Factor Inhibitor of DNA Binding 1 to Selectively Target Endothelial Progenitor Cells Offers Novel Strategies to Inhibit Tumor Angiogenesis and Growth
Albert S. Mellick et al.
CANCER RESEARCH (2010)
VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2
Z. Zhang et al.
CELL DEATH AND DIFFERENTIATION (2010)
Activation of Proteinase-Activated Receptor 2 Stimulates Soluble Vascular Endothelial Growth Factor Receptor 1 Release via Epidermal Growth Factor Receptor Transactivation in Endothelial Cells
Bahjat Al-Ani et al.
HYPERTENSION (2010)
Alternate processing of Flt1 transcripts is directed by conserved cis-elements within an intronic region of FLT1 that reciprocally regulates splicing and polyadenylation
Christie P. Thomas et al.
NUCLEIC ACIDS RESEARCH (2010)
CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction
Kentaro Jujo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Inhibition of endothelial progenitor cell differentiation by VEGI
Fang Tian et al.
BLOOD (2009)
Lin-Sca-1+CD49fhigh Stem/Progenitors Are Tumor-Initiating Cells in the Pten-Null Prostate Cancer Model
David J. Mulholland et al.
CANCER RESEARCH (2009)
The molecular basis of VEGFR-1 signal transduction pathways in primary human monocytes
Vadim Tchaikovski et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Anti-angiogenesis therapy based on the bone marrow-derived stromal cells genetically engineered to express sFlt-1 in mouse tumor model
M. Hu et al.
BMC CANCER (2008)
The VEGF receptor Flt-1 spatially modulates Flk-1 signaling and blood vessel branching
Nicholas C. Kappas et al.
JOURNAL OF CELL BIOLOGY (2008)
Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis
Dingcheng Gao et al.
SCIENCE (2008)
VEGF Trap complex formation measures production rates of VEGF, providing a biomarker for predicting efficacious angiogenic blockade
John S. Rudge et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Corneal avascularity is due to soluble VEGF receptor-1
Balamurali K. Ambati et al.
NATURE (2006)
Direct evidence for endothelial vascular endothelial growth factor receptor-1 function in nitric oxide-mediated angiogenesis
Shakil Ahmad et al.
CIRCULATION RESEARCH (2006)
Myeloid lineage progenitors give rise to vascular endothelium
Alexis S. Bailey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization
Bin Li et al.
FASEB JOURNAL (2006)
VEGF receptor signalling - in control of vascular function
AK Olsson et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Chemokines direct endothelial progenitors into tumor neovessels
H Spring et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
RN Kaplan et al.
NATURE (2005)
VEGI-192, a new isoform of TNFSF15, specifically eliminates tumor vascular endothelial cells and suppresses tumor growth
W Hou et al.
CLINICAL CANCER RESEARCH (2005)
Contribution of bone marrow-derived endothelial cells to human tumor vasculature
BA Peters et al.
NATURE MEDICINE (2005)
Role of β2-integrins for homing and neovascularization capacity of endothelial progenitor cells
E Chavakis et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Post-transcriptional control of expression of sFlt-1, an endogenous inhibitor of vascular endothelial growth factor
WR Huckle et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfimction, hypertension, and proteinuria in preeclampsia
SE Maynard et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
TL1A is a TNF-like ligand and functions as a T cell for DR3 and TR6/DcR3 costimulator
TS Migone et al.
IMMUNITY (2002)
A novel secreted splice variant of vascular endothelial cell growth inhibitor
LJ Chew et al.
FASEB JOURNAL (2002)
Modulation of endothelial cell growth arrest and apoptosis by vascular endothelial growth inhibitor
JY Yu et al.
CIRCULATION RESEARCH (2001)
Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth
D Lyden et al.
NATURE MEDICINE (2001)